Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: New Board Member, VP at Biomatrica

Premium

Biomatrica said this week that Nicolas Barthelemy has been added to the company's board of directors while Jeff Whitmore has joined the company as vice president of commercial development.

Barthelemy most recently served at Life Technologies, including as chief commercial officer (president, global commercial operations), president of the cell systems division, senior VP of the cell culture systems division, and senior VP of global operations. Prior to his time at Life Technologies, he held several senior management positions at Biogen Idec. He holds an MS in chemical engineering from the University of California, Berkeley, and an engineering degree from École Supérieure de Physiques et Chimie Industrielles in Paris.

Whitmore joins Biomatrica from Singulex, where he was vice president of life science sales. He also served as vice president of imaging sales at ProteinSimple; executive vice president of global sales at Alpha Innotech; and director of European life science sales at Molecular Devices.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.